Member Info for chester18

As the late, great, Bobby Ball would say ...

" I'm so excited, .... Rock on Tommy "

Chester.

@scotlouie

Thank you for clearing that up.

I've watch both youtube suggestions making notes so I'm beginning to understand exactly where Angle are in their development and implementation of the Parsortix system.

The addition of the two clinical labs (UK and USA) is also a well thought through strategy.

Chester.

Hi BOJO

Did he not correct himself to say that the Ovarian trial is in Enrolment and hoping it to be complete early next year. Does this mean the Enrolment will be completed?

Chester.

Researcher1

What an excellent response and gives me a great starting point. I can use this as a base to understand how the company intends to penetrate the potential market and where their priorities may be.

Many thanks

Chester.

I should point out that the reason for my interjection is because this board is where we should be discussing Scancell and it's amazing science but you keep on nitpicking at other people's posts.

In fact your continual abrasive style causes the feeling that you have an underlying ulteria motive.

Maybe 'Aimbig' gave of the same effervescent aura.....

Chester.

Perfectly demonstrated...

Bravo..

Chester.

Very simply, addressed to your goodself.

You show such concern for who this Aimbig could be that there are only two possible answers :

A) You are the reincarnation of the said historical poster.

B) You are too sensitive to any innuendo about your character.

"Simples"

Chester.

Cheers BOJO

I would have thought there are some on this board who would have a complete insight into the way the business can ramp up revenues after the FDA approval.

If I were a long term investor ( which hope to be considered in the future ) I would already know the answer.

But, as you say if there is no info forthcoming from this board I will email the company and report back here.

Chester.

What an overly complex deflection.

Chester.

Being relatively new to Angle I'm interested to know how many Parsortix Systems can be manufacture per month or per year given the FDA approve the system.

Is there information available in any previous Broker notes or company announcements.

I would really appreciate if anyone can shed light on the potential roll out of the systems and the Parsortix Cassettes.

Chester.

Newcrest 6 week update very possibly on Monday

Chester.

Don't forget that Spreadex could be exiting or like the Lombard holding RNS, one of our larger investors could be adjusting their position. What is needed is either confidence that the journey ahead is towards a much higher price or panic if you think its going back to .3p.....

These are the trials of investing, trying to guess every twist and turn of the price.

I'm confident that when the business update comes it will be positive because they have £14m to spend and I'm sure that its currently being put to good use.

Chester.

Morning RN1MLT

My analysis brought me to the same conclusion, Breakeven by mid 2022.

All the solid momentum in this share will come from Sales and Turnover growth. The next big impact will be the announcement that the first phase of development at San Antonio has been completed and commissioned.

Three months after that the sales will start to grow rapidly, especially if the pandemic in the USA is being controlled properly.

2021 is the pivitol year for TRX.

Chester.

Also, I have added you to the predictions list... : )

Certainly looks like a strengthening of the BOD to me. What we PI's are still don't know is how valuable the ' mystery ' deal is going to be and with whom.

It could well be that the medium term goal is to rapidly build the customer base and turnover in preparation of a merger or takeover, once the business is on a profitable footing.

At some point we will received an update that will fill in some of the blanks but one thing that is positive for the near future is that our MCap is still tiny compared with the potential growth in sales and profits.

Chester.

There were 9 very large late trades including one trade :

831,560 shares @ 40.25p = £334,702.90

Beautifully controlled SP by the MM's.

Chester.

Lombard Odier Management.

Reduction in holding of 17,582,500 shares, rough value at .51p = £89,700 so maybe they had bills or dividends to pay out.

Chester.

Hi Schlemiel

Good to see you posting, to me you're one of the founding posters and you are missed. As has been said, buy a few before they go up to 40p and join us as GGP go a mining...... : )

All the best to you

Chester.

@DarrenBuffer

The SP is just in a Cycle, no massive news prospects until the FDA ruling next April / May so as the Jupiter Fund leaves there is little appetitive for the shares at this time.

But what about when we get to February, March and April the interest in the possibility of the first ever 'Cancer Blood Biopsy' system will be palpable.

The share price at 40p is a steal so 35p will be ridiculous and I will definitely find a way to add more if that happens.

On FDA approval the business is going to be worth 3 or 4 times the current MCap just on the future possibilities of income growth. Obviously if the FDA push back and need more information / data then we have to reset our expectations.

Chester.

@Sandhopper* Done, Star added ....

@learn19 you have been added to the list.....

With regards to the charity donations, when the winner nominates the charity of their choice all those who have pledged to donate will be asked to make their own separate donations direct to that particular charity.
All to be done on a trust basis.

I certainly don't want anyone thinking that I want you to send it to me, absolutely not.

The more that pledge the greater the benefit to that charity.

All the best

Chester.

If we attribute the 30m sell last Monday to Spreadex and then we saw a holdings RNS taking them under the 3% radar they still held 100 / 150m shares so they may well be taking advantage of this spike.

I think if we see some large sells at the end of play today it is very probable to be them.

Chester.